Updated on 8 July 2014
Taiwan has a 3 percent share in the bioscience market of the Asia-Pacific region.
The top three companies in Taiwan during 2013 were Grape King, Excelsior Medical, and St. Shine Optical.
Most of the companies in the Top 10 list are in the $100-200 million range.
A few key developments in Taiwan include:
Taiwan based TaiGen Biotechnology collaborated with Russian firm R-Pharm to develop and commercial- ize nemonoxacin (Taigexyn), a novel antibiotic for the treatment of bacterial infections.